ClinicalTrials.govpublic full text
A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapy
prostate neoplasms, prostate cancer, metastatic castration resistant prostate cancer, abiraterone acetate, jnj-212082, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 842906
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.